Company
Kyverna Therapeutics
| Industry | clinical-stage cell therapy company with the mission of engineering a new class of therapies for autoimmune diseases |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Kyverna Therapeutics | Series B Extension | 2023-08-03 |
Company
| Industry | clinical-stage cell therapy company with the mission of engineering a new class of therapies for autoimmune diseases |
|---|
| Company | Round | Date |
|---|---|---|
| Kyverna Therapeutics | Series B Extension | 2023-08-03 |